Satsuma Pharmaceuticals
在场
Satsuma Pharmaceuticals 是一家在股票代码 STSA (US) 下上市的公司。
涉及Satsuma Pharmaceuticals的并购和融资。
- Shin Nippon Biomedical Laboratories has announced the acquisition of Satsuma Pharmaceuticals (公布2023四月18号).
高管
查看带有其 9 名主要高管的组织结构图
Satsuma Pharmaceuticals 搜索最多的简介
- Ryoichi Nagata, President, Chief Executive Officer and Director
- Akihisa Mori, Board Member
- Shu-Ichi Kanazashi, Board Member
创建提醒
跟踪 Satsuma Pharmaceuticals 的高管变动
药店
Satsuma Pharmaceuticals 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Satsuma Pharmaceuticals 的最新新闻稿
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- View more press releases Close
通过电子邮件
